We have determined the location of cis-acting elements that are important for the expression of RPO21 and RPO22, genes that encode the two largest subunits of RNA polymerase II (RNAPII) in Saccharomyces cerevisiae. A series of 5′-end deletions and nucleotide substitutions in the upstream regions of RPO21 and RPO22 were tested for their effect on the expression of lacZ fusions of these genes. Deletion of sequences from -723 to -693 in RPO21, which disrupted two Reb1p-binding sites and an Abf1p-binding site, resulted in a 10-fold decrease in expression. A T-rich region downstream of these sites was also important for expression. Deletion of sequences from -437 to -392 in the RPO22-upstream, which resulted in a 30-fold decrease in expression, indicated that the Reb1p-and Abf1p-binding sites in this region were important for RPO22 expression, as was a T-rich sequence immediately downstream of these sites. The RPO21 and RPO22 upstream regions were capable of interacting in vitro (gel-mobility-shift assays) with Reb1p and Abf1p. The similarities in the type and organization of elements in the upstream regions of RPO21 and RPO22 suggest that expression of these genes may be regulated coordinately.
INTRODUCTION
RNA polymerase II (RNAPII) is responsible for the synthesis of mRNAs and some small nuclear RNAs in eukaryotic cells. In the yeast Saccharomyces cerevisiae, the enzyme is composed of subunits encoded by 12 different genes that are scattered throughout the yeast genome (1, 2) . Five of the subunits are also found in RNAPI, which synthesizes rRNA, and in RNAPIII, which synthesizes tRNA, 5S RNA and U6 snRNA.
Little is known about the biosynthesis of RNAPII subunits in yeast, despite the fact that this enzyme plays a central role in the expression of thousands of genes whose transcript levels are likely to be influenced by the cellular amount of active RNAPII (3) . For this reason it is important to understand the mechanisms involved in maintaining the appropriate amount of enzyme. A consideration of the biosynthesis of multi-subunit enzymes such as RNAPII leads to the question of whether subunit synthesis is coordinated so as to produce the required molar ratio of subunits. In Escherichia coli, coordinate synthesis of the three proteins that make up the core RNAP results in subunit levels that reflect closely the stoichiometry of each subunit in the enzyme (4) . Although the mechanisms involved in this regulation are not understood fully, it is clear that coordinate synthesis of the two largest subunits of bacterial RNAP, β and β′, is due in part to the fact that the genes encoding these subunits lie in the same operon and thus are transcribed from the same promoters (4) .
One mechanism for generating similar amounts of expression from genes that act in a common biochemical pathway is the use of similar transcriptional control elements. For example, in S.cerevisiae the Gal4p transcription factor acts through a defined upstream regulatory sequence (UAS) to control the expression of a number of genes required for galactose metabolism (5) . Transcription of ribosomal-protein genes is controlled in a similar manner. In this case, the expression of many of the yeast genes that encode protein subunits of the ribosome is controlled by similar cis-acting elements, which are located upstream of the start site of transcription. These elements often contain one or two binding sites for Rap1p (6) or Abf1p (7), transcription factors that have important roles in coordinating the expression of ribosomalprotein genes (8) .
A similar mechanism may affect the expression of genes encoding subunits of RNAPIII. An analysis of the upstream regions of RPC160 and RPC40, two of the genes encoding subunits of RNAPIII in S.cerevisiae, has shown that binding sites for the transcription factor Abf1p are present (9) . A deletion analysis of the upstream region of RPC40 suggested that the binding site for Abf1p plays a significant role in the expression of this gene (9) . It is possible that Abf1p has a role in ensuring a similar level of expression from genes encoding subunits of RNAPIII.
We have undertaken an investigation of the biosynthesis of RNAPII in S.cerevisiae in order to gain a better understanding of the mechanisms that maintain a normal level of this enzyme. Our approach has been to determine which elements in the upstream 
MATERIALS AND METHODS

Strains and media
The S.cerevisiae strain used in this study was W303-1a (MATa can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 ade2-1) . Growth media were prepared and yeast transformations were performed as described (10, 11) . All plasmids were propagated in E.coli strain XL-Blue (12) .
Plasmids
DNA manipulations were performed essentially as described (13) . pYF1495 is a yeast shuttle-vector (LEU2; 2µm origin of replication) carrying an in-frame fusion of RPO21 and lacZ. Details of the construction of this and other plasmids described here may be obtained from the corresponding author. A series of 5i-end deletions was generated in the RPO21-upstream region by digestion with HindIII at -1585 (the A of the RPO21 initiation codon is +1) and Bal31 exonuclease. The ends were filled with Klenow fragment of DNA polymerase I and HindIII linkers were ligated to the ends. HindIII-AvrII fragments (AvrII is at +171) from this set of 5i-end deletions were cloned into the same sites of pYF1495. The rpo21-∆UAS allele was constructed by: (i) inserting a HindIII linker at an end-filled BstEII site after -724 in the RPO21-upstream region; (ii) cutting the resulting plasmid with HindIII to isolate a 860 bp HindIII-HindIII fragment containing RPO21 sequences from -1585 to -724; (iii) cloning this fragment in the HindIII site of a derivative of pYF1495 that has a 5′ -deletion in the upstream region of RPO21 up to -692. The resulting internal deletion/insertion is shown in Figure 2A (bottom).
pYF1476 is a yeast shuttle-vector (LEU2; 2µm origin of replication) carrying an in-frame fusion of RPO22 and lacZ. 5′-end deletions of the RPO22-upstream region were generated by cleaving at unique sites in the upsteam region of RPO22, filling the ends, adding HindIII linkers, digesting with HindIII and religating the DNA. HindIII-BamHI fragments (encompassing sequences from the 5i-end up to +81) were cloned into the same sites of pYF1476.
Plasmids with mutations in the RPO21 and RPO22 UASs were generated either by using oligonucleotides with UAS element mutations and a second downstream oligonucleotide to amplify the UAS sequence by PCR or by using a PCR-based site-directed mutagenesis technique that was described previously (14) . The amplified regions were cloned and sequenced to confirm that the mutated plasmids contained only the desired mutations. One of the site-directed mutations introduced three nucleotide substitutions in the putative Abf1p-binding site in the RPO22-upstream region. At position -383, a G is changed to A and at positions -393 and -392, CG is replaced with AA (see Fig.3B , top). The latter two substitutions created a new EcoRI site at -394 to -389 in the RPO22-upstream region. The new EcoRI site was used to create a 5′-deletion (to -391) in the upstream region of RPO22 shown in the fourth line of Figure 3A . The asterisk in Figure 3A refers to the additional G to A substitution at -383 in the upstream region, which, as mentioned above, introduced another alteration in the Abf1p-binding site. The rpo22-nUAS allele was created by subcloning a HindIII-HincII fragment containing sequences of the RPO22-upstream region from -1200 to -438 and an EcoRI-BamHI fragment containing RPO22 sequences from -391 to +82 into pYF1476, creating a RPO22-lacZ fusion gene with the deletion/ insertion mutation shown in Figure 3B (bottom). Note that this allele also contains the G to A substitution at -383.
Plasmids were generated with the UAS of RPO21 cloned upstream of a UAS-less CYC1-lacZ gene. The vector, pDJ22, was derived from pLG670-Z (15), a yeast shuttle-vector (URA3, 2µm) containing a fusion of CYC1-upstream sequences to the lacZ gene. pDJ22 was created by deleting sequences in pLG670-Z from the SmaI site at the 3′-end of URA3 to the SphI site 12 bp upstream of the 5′-most TATA box of CYC1 and replacing them with a BglII linker. DNA fragments from wild-type and mutated RPO21-upstream sequences were amplified by PCR using two oligonucleotides, DA23 (5′-GGGGATCCGA-CTATCATACGGTAACC-3′) and DA24 (5′-GGGGATCCACCG-ACAATCGTCTTTAG-3′). Amplified products contained sequences from -740 to -674 that encompass the UAS of RPO21. The PCR products were digested with BamHI and were cloned into the BglII site of pDJ22. Resulting plasmids were sequenced to confirm the number of inserts, insert orientation and the absence of unwanted mutations.
β-galactosidase assays β-galactosidase activity was measured as described by Miller (16) . Cells were grown in selective medium at 30_C. For each measurement, β-galactosidase activity was determined on at least three independent cultures.
Electrophoretic-mobility-shift assays (EMSA)
Assays were performed as described (17) except that DNA-protein mixtures were separated on 5% acrylamide gels. Probes and non-labeled-competitor DNA from RPO21 were generated by PCR using the primers DA23 and DA24, described above. The non-labeled-competitor DNA from the RPO22 -upstream region was a HindIII-RsaI fragment containing -437 to -209 of RPO22-upstream sequence. The probe with the Reb1p site from the GAL1-GAL10 intergenic region (provided by C. Brandl) was a 104 bp BamHI-EcoRI fragment from plasmid his3-GG227 (18) . The probe containing the Abf1p site from MATa was the 136 bp BamHI fragment of pB2ABF1 (19) (provided by L. McBroom). Probes were end-labeled using Klenow fragment of DNA polymerase I and [α-32 P]dATP.
Proteins used for gel-shift assays were either: (i) purified yeast Abf1p, provided by A. Buchman (17) or (ii) an extract from an E.coli strain expressing REB1 (20; strain provided by J. Warner) or (iii) yeast whole-cell extract from a wild-type yeast strain (provided by S. Nouraini) that was prepared as described (21) . Estimations of the relative intensities of complexes were obtained by PhosphorImager analysis, using ImageQuant software (Fig. 4A) , or by scanning autoradiographs and quantifying band intensities using NIH image software (Fig. 5) .
Nucleotide sequence analysis
The RPO21-upstream region and various constructs were sequenced by the chain-termination method (22) , using a combination of promoter deletions and primers that had been synthesized on the basis of the RPO21 or RPO22 sequences. Single-or double-stranded DNA templates were used. 
RESULTS
Deletion and sequence analyses of the RPO21-upstream region
The transcripts expressed from RPO21 have unusually long leader sequences with transcriptional start sites at -565, -510 and -400 (the A of the initiation codon is defined as +1) (23) . In order to locate DNA sequence elements in the upstream region of RPO21 that are important for RPO21 expression, a plasmid (pYF1495) was constructed that contains an in-frame fusion of RPO21 to the lacZ gene of E.coli. In this plasmid ∼1600 bp of RPO21-upstream sequences as well as the first 57 codons of the open-reading frame (ORF) are fused to lacZ (Fig. 1) . The upstream sequences used in constructing this plasmid probably contain all sequences that are important for the expression of RPO21, since they include the transcriptional start site furthest from the initiation codon as well as an additional 1000 bp of upstream sequence. A series of 5′-end deletions was made in the RPO21-upstream region in pYF1495 and the resulting plasmids were introduced into the wild-type yeast strain, W303-1a. β-galactosidase assays performed on the transformants indicated Fig. 2A, top) . The sequences that were removed, as well as 12 bp added in an internal deletion in the RPO21 UAS (rpo21-∆UAS), are indicated ( Fig. 2A , bottom). (B) Line (a) is a representation of the wild-type RPO21 UAS. In subsequent lines (b-h) the absence of a black box indicates the introduction of nucleotide substitutions at the respective site(s). Line (i) shows the internal deletion of the RPO21 UAS. Line (j) represents a UAS-less CYC1-lacZ fusion gene with no insert upstream of the TATA box. The first column of numbers ('RPO21') shows the levels of β-galactosidase activity due to plasmids bearing 1585 bp of RPO21-upstream sequences with the indicated mutations in the RPO21 UAS. The second column of numbers ('forward') shows the levels of β-galactosidase activity due to plasmids bearing a UAS-less CYC1-lacZ fusion gene with 79 bp inserts bearing the RPO21 UAS cloned 12 bp upstream of the 5′-most TATA box of CYC1. The last column ('reverse') indicates the activity of a CYC1-lacZ fusion with the RPO21 UAS inserted upstream in the opposite orientation as in the upstream region of RPO21.
that deletion of sequences upstream of position -728 did not have a significant effect on the expression of RPO21-lacZ (Fig. 1) .
The sequences downstream of -315, including the RPO21 ORF, have been determined previously by Allison et al. (24) . The DNA sequence of the region from -1585 to -315 was determined (data not shown) and indicated an ORF extending from -1557 to -817. The presence of the ORF is consistent with our observations that these sequences do not have a role in the expression of RPO21.
In contrast, a further deletion to -692 resulted in a 10-fold decrease in expression (Fig. 1) . Sequences from -728 to -692 contain all or part of three putative binding sites for yeast transcription factors ( Fig. 2A, top) . The two 5′-most elements match closely the consensus sequence for binding sites of Reb1p (Grf2p) (25) . The third, and 3′-most element, matches closely the consensus sequence for a binding site for Abf1p (26) . We shall refer to the sequences that encompass these three putative transcription-factor-binding sites as the RPO21 UAS.
Deleting sequences up to -632 resulted in an additional 10-fold decrease in gene expression. Removal of 38 bp from the 5′-end of RPO21-lacZ that has 670 bp of upstream sequences resulted in a 7-fold decrease in expression (Fig. 1, compare lines 6 and 7) . The removed sequences are part of a region (-674 to -622), downstream of the UAS, which is rich in thymidine residues (30 of 52). The sequences spanning the region of the UAS and transcriptional start sites were scanned for potential binding sites for the TATA-binding component of the general transcription factor, TFIID. No matches to the consensus binding site were found, although the sequence is rich in adenine and thymidine residues. We conclude that sequences downstream of -728 are sufficient for the full expression of RPO21, and that two regions are important for RPO21 expression: (i) the RPO21 UAS, composed of two putative Reb1p-binding sites and one putative Abf1p-binding site; (ii) a T-rich sequence downstream of this UAS.
In order to test whether sequences upstream of position -728 act redundantly with the sequences between -728 and -692, a plasmid was constructed that carries the entire 1585 bp RPO21-upstream sequence fused to lacZ, except that sequences from -723 to -693 inclusive were deleted and replaced by a HindIII linker (Fig. 1, rpo21 -∆UAS in Fig. 2A) . A strain bearing this plasmid showed a 10-fold decrease in RPO21-lacZ expression compared with one carrying the wild-type promoter; the reduction in expression was comparable with that seen with a deletion up to -692. Therefore, removal of sequences from -723 to -693 is sufficient to cause a 10-fold decrease in RPO21 expression and these sequences are necessary for full expression of RPO21.
Mutational analysis of the RPO21 UAS
Site-directed mutagenesis was used to introduce substitutions in the RPO21 UAS (Fig. 2 ). Plasmids were constructed that contain 1585 bp of RPO21-upstream region with mutations in the three elements of the UAS (Fig. 2B , line h), mutations in any single site (Fig. 2B, lines b-d) or mutations in any two of the sites (Fig. 2B , lines e-g). The chosen mutations ( Fig. 2A, top) have been shown in other Reb1p-and Abf1p-binding sites (9, 25, 27) to reduce protein binding in vitro or transcriptional activation activity in vivo.
When mutations were introduced into all three sites (Fig. 2B , line h), a 10-fold decrease in expression was observed, equal to the decrease observed with a deletion that removed all or part of the three elements that make up the UAS (Fig. 2B, line i) . When any one of the three elements was wild-type, and the other two were mutated, 50-70% of wild-type activity was observed (Fig. 2B , lines e, f and g). Finally, activation of transcription by UAS sequences with mutations in any single element (the other two being wild-type) was at levels that ranged from 70 to 85% of wild-type. These data suggest that the RPO21 UAS is composed of three distinct functional elements, all of which are necessary for full activity and all of which are partially redundant.
Activity of the RPO21 UAS in a heterologous promoter
A DNA fragment carrying the RPO21 UAS was inserted in a position upstream of the CYC1 basal promoter and start sites of a CYC1-lacZ fusion gene devoid of other upstream-activating sequences. The DNA fragment used in these experiments spans nucleotides -740 to -674 and contains the two putative Reb1p-sites and the putative Abf1p-binding site.
Insertion of the wild-type RPO21 UAS stimulated expression by >400-fold over background ( Fig. 2B ; compare line a under 'forward' with line j). When the UAS was inserted in the reverse orientation, expression was enhanced by >100-fold compared with basal level (Fig. 2B ; compare line a under 'reverse' with line j). DNA sequences that are able to increase the expression of another promoter in an orientation-independent manner meet the criteria of upstream-activating sequences (28); therefore, sequences from -740 to -674 in the RPO21-upstream region behave as a bona fide UAS.
We tested whether the contribution of the putative Reb1p-and Abf1p-binding sites was the same in the context of the CYC1 promoter as in the RPO21 promoter. The expression was determined of RPO21 UAS-CYC1-lacZ fusion genes with mutations in either the single putative Abf1p-binding site (Fig. 2B,  row d ) or in the two putative Reb1p-binding sites (Fig. 2B, row  g ). A UAS with mutations in the putative Abf1p-binding site activated the reporter gene to 26% of the wild-type level, whereas a UAS with mutations in the two putative Reb1p-binding sites had 54% of wild-type activity. Mutations in all three sites reduced the activity of the UAS to background levels (Fig. 2B, row h) . Hence, in the context of the CYC1 promoter, the combined transcriptional activity due to individually acting components of the RPO21 UAS was less than the activity of the UAS as a whole. Therefore, in contrast with their activity in RPO21 promoter, the elements do not act in a partially-redundant manner in the context of the CYC1 promoter. A possible explanation for this behavior is discussed below.
Deletion analysis of the RPO22 promoter
A plasmid (pYF1476) was constructed with 1200 bp of RPO22-upstream sequences as well as 27 codons of the ORF fused in-frame to lacZ. It has been shown by S1-nuclease analysis of RPO22 transcripts that the start site of transcription is at -260 ± 25 bp (the A of the initiation codon of RPO22 is defined as +1) (29) .
β-galactosidase assays of a series of 5′-end deletions revealed that sequences upstream of -440 were not required for full expression (Fig. 3A) . The removal of 46 bp to position -391 resulted in a >30-fold decrease in expression. The DNA sequences of the RPO22-upstream region (29) that lie between -410 and -380 resemble the consensus-binding sites for Reb1p and Abf1p (Fig. 3B) ; sites with the same non-conformity with the Reb1p consensus have been shown previously to bind Reb1p (25, 30) . The sequences that match the Abf1p-consensus-binding site are in the opposite orientation to those in the UAS of RPO21. Since a deletion that removed all or part of the putative Reb1p-and Abf1p-binding sites resulted in decreased expression of RPO22-lacZ, this region is important for the expression of RPO22. We refer to this region as the RPO22 UAS.
The T-rich region that lies downstream of the UAS (-380 to -345; 23 of 36) may be important for the expression of RPO22, since a deletion of 211 bp encompassing this region resulted in a 10-fold decrease in expression (Fig. 3A) . Our results, however, do not exclude the possibility that removal of sequences immediately downstream of the T-rich tract (-344 to -180) also contributes to the observed decrease in expression. Deletion of sequences from -437 to -392 (rpo22-∆UAS; Fig. 3B ) resulted in a level of expression similar to that of a deletion of all sequences up to -391. Thus, these sequences (-437 to -392) are important for the expression of RPO22. A scan of sequences containing the UAS and start-site region of RPO22 revealed no match to the consensus binding site of TFIID.
Nucleotide substitutions were made in either or both of the putative Reb1p-and Abf1p-binding sites (Fig. 3B, top) . The substitutions in the putative Reb1p-binding site alter highlyconserved residues in the consensus binding site (18) . The changes introduced into the putative Abf1-binding site have been shown to reduce binding of Abf1p in vitro (27, 31) and activation of transcription in vivo (31) .
Mutation of the putative Abf1p-and Reb1p-binding sites resulted in a 56-fold decrease in expression, similar to that observed with deletion of the RPO22 UAS (Fig. 3C) . Mutation of only the putative Abf1p-binding site resulted in retention of 75% of wild-type activity; mutation of only the putative Reb1p-binding site yielded a UAS with 55% of wild-type activity. Together, these results show that: (i) both putative binding sites are necessary for full activity of the UAS; (ii) these elements are partially redundant in their effects on the expression of RPO22; (iii) the T-rich sequence may be important for the expression of RPO22.
Electrophoretic mobility shift assay (EMSA) analysis of the RPO21 UAS
DNA fragments derived from the promoters of RPO21 and RPO22 were used as probes or competing DNA in electrophoretic mobility shift assays (EMSAs) (32) . Incubation of a DNA fragment containing the wild-type RPO21 UAS with a crude yeast whole-cell extract (WCE), revealed two DNA-protein complexes Nucleic Acids Research, 1996, Vol. 24, No. 22 4549 (complexes 1 and 2, Fig. 4A, lane 2) . Mutation of the Abf1p-binding site (lane 3) or of the two Reb1p-binding sites (lane 4) caused a modest (<2-fold) reduction in the amount of complex 1. In contrast, mutations in all three elements abolished complex 2 and reduced complex 1 by >10-fold (compare lanes 2 and 5). We conclude that the Reb1p and Abf1p elements of the UAS of RPO21 are able to bind to proteins in a sequence-specific manner. Furthermore, mutations that reduce the activity of the UAS in vivo (Fig. 2B ) also reduce the strength of DNA-protein interactions in vitro.
An extract from an E.coli strain over-expressing REB1 (provided by J. Warner) (20) was used to test whether the RPO21 UAS can bind Reb1p. With the wild-type RPO21 UAS, a complex migrated at the same position as complex 1 (Fig. 4A,  compare lanes 2 and 7) . Two additional faster-migrating complexes were also observed; these probably result from interactions between the probe and proteolytic fragments of Reb1p. Formation of complex 1 with a probe that carried mutations in both potential Reb1p-binding sites was reduced by 10-fold (lane 9). Mutations in the putative Abf1p-binding site had no significant effect on the interaction of Reb1p with the probe (lane 8) and a probe with mutations in all three elements showed a pattern similar to that with mutations in the two Reb1p-binding sites (lane 10). These data suggest that Reb1p can bind specifically in vitro to the UAS of RPO21. Although the mutations in the Reb1p sites did not completely abolish complex formation in vitro, the reduction in binding is sufficient to impair their function in the RPO21 promoter in vivo (see Fig. 2B ). Residual binding of Reb1p to the mutated sites in vivo may account for the unexpectedly large activation of the CYC1 promoter by the RPO21 UAS carrying mutations in both Reb1p sites (leaving a single Abf1p site, Fig. 2B ; row g), perhaps through a synergistic interaction between Abf1p and Reb1p (see Discussion).
When wild-type RPO21 UAS DNA was combined with purified Abf1p (17) a single major complex was observed that migrated in a position corresponding to complex 1 (Fig. 4A , compare lanes 2 and 12) and this was reduced 15-fold by mutations in the putative Abf1p-binding site (lane 13). Mutations in the two Reb1p-binding sites showed no effect (lane 14) , while mutations in all three sites showed a similar pattern to that seen with mutations in only the Abf1p site (lane 15). These data suggest that Abf1p interacts specifically with the UAS of RPO21. Mutations that disrupt the function of the element in vivo (Fig. 2B) , also disrupt the interaction of Abf1p with the UAS in vitro.
The suggestion that the UAS of RPO21 contains two Reb1p-binding sites was tested by adding to a wild-type RPO21 UAS probe increasing amounts of extract from E.coli expressing REB1. At low levels of Reb1p, a single major complex (complex 1) was seen, which was chased into the slower-migrating complex 2 with the addition of increasing Reb1p concentration (Fig. 4B,  lanes 2-4) . This complex migrated to the same position as complex 2 (Fig. 4A, lane 2 and Fig. 4B, lane 7) . We conclude that the RPO21 UAS has two binding sites for Reb1p.
The observation that elements of the RPO21 UAS are partially redundant in vivo (Fig. 2B ) may reflect the fact that only a subset of the three sites is occupied at one time. Radioactively-labeled wild-type RPO21 UAS was incubated with purified Abf1p and an extract from E.coli expressing REB1 in order to test this possibility. The presence of a third complex (complex 3, Fig. 4B , lane 6) at a higher gel position suggested that all three sites in the UAS can be occupied simultaneously in vitro. Complex 3 was also detected with a yeast whole-cell extract (lane 7).
These results may indicate that complex 1, which is formed with a yeast whole-cell extract, is a mixture of two complexes, each of which include one molecule of Abf1p or one molecule of Reb1p. This hypothesis is supported by the observation that complex 1 is reduced by the introduction of mutations in all three binding sites (Fig. 4A, lane 5) . Similarly, complex 2 probably contains a mixture of probe bound either to two molecules of Reb1p, or to one molecule of Abf1p and one of Reb1p. This hypothesis is supported by the observation of a reduction in complex 2 when either the Abf1p-binding site (Fig. 4A, lane 3) or both of the Reb1p-binding sites (Fig. 4A, lane 4) are mutated. Finally, complex 3 (Fig. 4B, lane 7) may represent the RPO21 UAS probe bound to two molecules of Reb1p and one molecule of Abf1p. Regardless of the exact composition of each complex, the formation of three complexes is clear and these complexes are abolished by mutations that have been shown to reduce the binding of Abf1p and Reb1p. Thus, we conclude that the RPO21 UAS contains two sites that bind Reb1p and one site that binds Abf1p.
Competition of Reb1p-and Abf1p-DNA complexes with the RPO21 UAS and RPO22 UAS
Reb1p was combined with a radioactively-labeled DNA fragment containing a known Reb1p-binding site from the GAL1-GAL10 intergenic region (18); DNA fragments containing the UASs of RPO21 and RPO22 were used as non-labeled competitors. As expected, a single major complex was formed, which was reduced 15-fold by the addition of a 10-fold molar excess of non-labeled wild-type RPO21 UAS (Fig. 5, compare lanes 2 and 3) . Non-labeled competitor carrying mutations in both Reb1p-binding sites reduced the amount of complex by <2-fold (lane 6). Competitors with a mutation in only one Reb1p-binding site (either one) were almost as effective as the wild-type UAS, suggesting that both sites are able to bind Reb1p (lanes 4 and 5). A 10-fold molar excess of a DNA fragment with the wild-type UAS of RPO22 was able to compete for binding of Reb1p to the Reb1p-binding site of GAL1-GAL10 (Fig. 5, lane 7) ; however, DNA with mutations in the putative Reb1p-binding site of RPO22 failed to compete (lane 8).
These data suggest that the UAS of RPO22 can interact with Reb1p in vitro in a sequence-specific manner, since mutations that impair the activity of the Reb1p site in vivo (Fig. 3C ) also reduce the ability of the site to interact with Reb1p in vitro.
Competition experiments with a complex formed with purified Abf1p and a radioactively-labeled DNA fragment from MATa (19) yielded similar results (Fig. 5, lanes 10-14) , suggesting that the RPO22 UAS can interact specifically with Abf1p.
DISCUSSION
Our results indicate that the expression of two genes, which encode subunits unique to RNAPII in S.cerevisiae, is controlled by similar cis-acting upstream elements. Mutation of two Reb1p-binding sites and an Abf1p-binding site results in a 10-fold decrease in RPO21 expression, while mutation of a Reb1p-binding site and an Abf1p-binding site results in a >30-fold decrease in the expression of RPO22. In both genes, the UAS is immediately upstream of a T-rich sequence which, when removed, decreases expression by an additional 10-fold.
We suggest that the similar elements in the UASs of RPO21 and RPO22 may serve to control coordinate synthesis of stoichiometric amounts of each subunit, which would minimize the wasteful expenditure of cellular energy associated with the production of one subunit in excess of others.
Regulation of RPO21 and RPO22 expression is similar in some ways to the regulation of genes that encode components of the ribosome, another multisubunit complex. Ribosomal protein (rprotein) genes are controlled by Abf1p or the related protein, Rap1p (8, 33, 34) and are regulated through the RAS/cAMP signal-transduction pathway. The increase in mRNA transcribed from many rprotein genes due to a nutritional upshift depends on two kinds of upstream elements: a T-rich stretch (35) and a functional Rap1p-(35-37) or Abf1p-(35) binding site. The increase in gene expression also requires cAMP-dependent-protein kinases (36, 37) and de novo protein synthesis (37) , indicating that phosphorylation of Rap1p (36) may not be sufficient for the response. Abf1p also is phosphorylated when cells are shifted to a rich carbon source (38) , suggesting that this modification may have a role in the regulation of rprotein gene expression.
Abf1p (TAF, BAF) and Reb1p (Grf2p), members of a family of highly-abundant DNA-binding proteins [which also includes Rap1p (6)], are involved in many functions. Abf1p binds the promoters of many genes, including those which encode rproteins (33, 34) and proteins involved in glycolytic functions (39) (40) (41) and is important for silencing at the HMR locus (7, 42) . Abf1p also has a role in DNA replication, since its binding is required for the function of some autonomously-replicating sequences (ARSs) and mutations in ABF1 that confer a temperature-sensitive phenotype on yeast, result in mitotically unstable ARS-CEN plasmids at the semi-permissive temperature (43) . Reb1p (Grf2p)-binding sites are important for the expression and termination of rRNA transcripts (44) , have roles in the activation and repression of ENO1 (30, 39) and were shown to be important for creating a nucleosome-free GAL1-10 intergenic region (45) . Reb1p-binding sites stimulate transcription in vivo (25) , but reduce the expression of CYC1 when interposed between the UAS and TATA box (46) . Reb1p also binds to telomeres and centromeres (25) .
How could these multi-purpose proteins function in coordinate expression of genes encoding subunits of RNAPII? As shown in Figure 6 , subunits unique to RNAPII encode seven genes which [with the exception of RPO29 (RPB9), in which only one potential Reb1p-binding site was found in the upstream sequences] have two or more potential-binding sites for Reb1p and/or Abf1p and one or two T-rich stretches. In all cases these elements cluster within ∼100 bp of each other. Although the orientation and relative positions of the sites vary, the similarity of the sequences and relative proximity to each other suggest that they might serve as functional units for the maintenance of similar (coordinate) levels of gene expression under various growth conditions.
Our results suggest that a T-rich sequence downstream of the RPO21 UAS, and perhaps the one downstream of the RPO22 UAS, are important for the expression of these genes. Homopolymeric dA:dT tracts show weak enhancement of the expression of a minimal CYC1 promoter but can act synergistically with Abf1p, Reb1p and other (usually upstream) DNA-binding factor sites to enhance gene expression (17, 25) . The synergistic activity of the elements depends on the distance between them, since activation of gene expression falls rapidly when sequences are interposed between the elements (25). Since they are spaced closely, it is possible that the UASs of RPO21 and RPO22 also act in synergy with the downstream T-rich tracts.
Our results indicate that an Abf1p-binding site located downstream of two mutated Reb1p-binding sites is able to enhance the expression of a CYC1-minimal promoter by 200-fold (Fig. 2B ). This level of enhancement is higher than reported previously for a single Abf1p site. Buchman and Kornberg (17) used a CYC1-lacZ reporter plasmid (pCZ∆) similar to the one used in this study, which also contained a cloning site 12 bp upstream of the 5′-most TATA site of the CYC1 promoter. In a study of the effect of seven different single Abf1p-binding sites, Buchman and Kornberg observed a maximum stimulation of 9-fold (table 2 in ref. 17) . They did, however, report a synergistic enhancement of up to 56-fold with two adjacent Abf1p sites. We suggest that the large enhancement of transcription which we observe with a single Abf1p site is due to a synergistic interaction between this site and the two mutated Reb1p sites, which may bind Reb1p at a significant level, albeit reduced compared to normal. In support of this hypothesis, we note the observation of residual binding of Reb1p to mutated sites in vitro (Fig. 4A) , even though the activity of these sites apparently is destroyed in the context of the promoter of RPO21.
We found that the elements of the RPO21 UAS are partially redundant in their roles as activators of RPO21 expression. The same elements, however, are not redundant when placed in the context of a minimal promoter. We also note that the RPO21 UAS has a greater effect on the expression of the CYC1 minimal promoter (400-fold) than it has in its normal context in the promoter of RPO21 (10-fold). These apparent discrepancies may be due to the presence of other elements in the RPO21 promoter. It has been suggested that homopolymeric dA:dT tracts may enhance the transcriptional-activating effect of other nearby elements that bind transcription factors by freeing the region of nucleosomes that may interfere with the binding of the factors (47) . If chromatin interference is a major impediment to the function of DNA-binding factors and a sequence in the promoter is present to counteract chromatin interference, then perhaps the effect of a single DNA-binding factor is not enhanced significantly by the binding of an additional factor. However, if a chromatinmodulating sequence is not present (for example, in a minimal promoter), then the binding of a second or third factor may stimulate the activity of the first factor in counteracting the negative effects of chromatin. This stimulation may be the result of enhanced binding or perhaps through increased interactions with general transcription factors that may also be adversely affected by chromatin (48) .
